CG Oncology (CGON) Institutional Ownership

26.56% of CG Oncology's stock is owned by institutional investors. Learn more on CGON's institutional investor holdings.

Of the 176 institutional investors that purchased CG Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($7.42M), Foresite Capital Management VI LLC ($2.22M), Price T Rowe Associates Inc. MD ($2.21M), Marshall Wace LLP ($1.73M), Bank of America Corp DE ($1.69M), State Street Corp ($1.67M), and Yu Fan ($1.58M).

Institutional investors have bought a total of 21,426,080 shares in the last 24 months. This purchase volume represents approximately $842.54M in transactions.

Of the 62 institutional investors that sold CG Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Braidwell LP ($1.41M), Orbimed Advisors LLC ($1.08M), Bank of America Corp DE ($988.42K), Pictet Asset Management Holding SA ($951.52K), Millennium Management LLC ($706.79K), ADAR1 Capital Management LLC ($346.74K), and CenterBook Partners LP ($326.12K).

Institutional investors have sold a total of 8,568,004 shares in the last 24 months. This volume of shares sold represents approximately $407.75M in transactions.